series-c-plus
Stage
2014
Founded
1
Investors
About
Genedrive is a UK-based pharmacogenetic testing company that develops rapid point-of-care diagnostic tests to guide safe and effective drug prescription in emergency and acute care settings. Its flagship products include the Genedrive CYP2C19 ID Kit for stroke patients and the Genedrive MT-RNR1 ID Kit to prevent antibiotic-induced hearing loss in newborns.
Explore Genedrive's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.